Gurus BioPharm is a biotech startup developing innovative drugs based on prostaglandin modification by Nitric Oxide donor. Our pipeline includes first-in-class molecules for these the indication:
1. Alopecia (passed pilot clinical trials)
2. Asthma (ready for Phase I)
3. COPD (ready for Phase I)
4. Glaucoma (preclinical stage)
5. COVID-19 vasculopathy (discovery stage)
6. COVID-19 pneumonia (discovery stage)
7. Coronavirus and flu (discovery stage)
8. Cancer drug enhancer (discovery stage)
9. Pulmonary arterial hypertension (discovery stage)
10. Stroke (discovery stage)
11. Erectile dysfunction (discovery stage)
12. Critical Limb Ischemia (discovery stage)
Company Details
- Employees
- 3
- Founded
- -
- Address
- 2093 Philadelphia Pike, Claymont,delaware 19703,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.gurus.bio
- Keywords
- NAL Investment Co Ltd.
- HQ
- Claymont, Delaware
Gurus Biopharm Inc. Questions
Gurus Biopharm Inc.'s website is http://www.gurus.bio
Gurus Biopharm Inc.'s LinkedIn profile is https://www.linkedin.com/company/gurus-biopharm
Gurus Biopharm Inc. has
3 employees.
View email and phone details for 3
employees at Gurus Biopharm Inc..
Gurus Biopharm Inc.'s industry is
Biotechnology Research
Gurus Biopharm Inc.'s top competitors are
Gxg Energy Corporation,
Mengx,
Neoceptual ™ Digital,
Teriaq Pharma,
Zahrat Haneen Pharmaceutical Co,
Makira Beauty,
Jumla,
Nal Investment Co Ltd,
Long Sheng Pharma,
Balayan Group.
Gurus Biopharm Inc.'s categories are Biotechnology Research
Gurus Biopharm Inc.'s founding year is 2011
